Willner, Michael Jay — Insider Profile

Insider Profile

Willner, Michael Jay

🔒 Follow — get an alert on any new filing

$CRDL

Companies Filed At

Open-Market Buys (2yr)

—

Buy Value (2yr, open-market)

Sep 06, 2024

Most Recent Trade

Credibility
Score

Hit Rate

-18.9%

Avg 90d Return

-17.7%

Median 90d Return

Evaluated Trades

-2.2%

Best Trade

-51.8%

Worst Trade

Hit rate and returns are based on 6 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Sep 06, 2024	$CRDL Cardiol Therapeutics Inc	—	Exercise	Buy	80,244	—	—	45
Sep 06, 2024	$CRDL Cardiol Therapeutics Inc	—	Exercise	Buy	80,244	—	—	45
Sep 06, 2024	$CRDL Cardiol Therapeutics Inc	—	Exercise	Sell	80,244	—	—	45
Sep 06, 2024	$CRDL Cardiol Therapeutics Inc	—	Exercise	Buy	80,244	—	—	45
Jul 10, 2024	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	100,000	—	—	45
Sep 29, 2023	$CRDL Cardiol Therapeutics Inc	—	Exercise	Sell	20,245	—	—	45
Sep 29, 2023	$CRDL Cardiol Therapeutics Inc	—	Exercise	Buy	20,245	—	—	45
Feb 22, 2023	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	100,000	$4.46	$446K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	121,480	$1.41	$171K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	60,000	$3.26	$196K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	60,000	$3.69	$221K	45

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.